Cervical Cancer

The FDA granted fast track designation to balstilimab in combination with zalifrelimab for the treatment of women with relapsed or refractory metastatic cervical cancer, according to the agents’ manufacturer.

Researchers found that 35% of OB-GYNs across the U.S. are aged 55 years or older, but only 19% of OB-GYNs are aged younger than 40 years — findings that point to a potential shortage of these physicians in the coming years.

Today is International HPV Awareness Day.

Adolescent obesity is linked to midlife cancer risk among men and women, highlighting the need to tackle obesity early in life, according to findings from a population-based study published in The Lancet Diabetes & Endocrinology.

The NCI awarded a 5-year, $8.3 million research grant to Weill Cornell Medicine, Moffitt Cancer Center and Universidade de Sao Paulo in Brazil to investigate strategies to prevent HPV-related cancers among individuals with HIV.

Last week’s top story in hematology/oncology examined how a traditional end to cancer treatment — the ringing of a bell — is a cause for celebration, but it can also provoke painful memories for patients.

One dose of the HPV vaccine appeared to be as effective as multiple doses in preventing preinvasive cervical disease among adolescents vaccinated between ages 15 and 19 years, according to results of a retrospective study published in Cancer.

High HPV vaccination coverage for girls and scaled-up screening and treatment may lead to the elimination of cervical cancer in most lower-middle-income countries over the next 100 years, according to results of two modeling studies published in The Lancet.

Cervical Cancer Awareness Month is observed every January.

Millions of women aged 15 to 20 years old in the United States may have received unnecessary Pap tests or bimanual pelvic exams in recent years, according to a study published in JAMA Internal Medicine.